BRIEF-EMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Side Effect

BRIEF-EMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Side Effect
Representative Image

European Medicines Agency: * EMA: ASSESSMENT OF WHETHER VACCINATION CAN CAUSE CAPILLARY LEAK SYNDROME (IS ONGOING FOR PFIZER AND MODERNA COVID-19 VACCINES

* EMA SAYS FOR SPIKEVAX, PRODUCT INFORMATION WILL BE UPDATED TO INCLUDE PARAESTHESIA (UNUSUAL FEELING IN THE SKIN) AS A RARE SIDE EFFECT * EMA: IN JANUARY 2022, PRAC CONCLUDED THAT TRANSVERSE MYELITIS SHOULD BE ADDED TO THE PRODUCT INFORMATION AS A SIDE EFFECT OF ASTRAZENECA VACCINE Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.